Brent Allan
Overview
Explore the profile of Brent Allan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
691
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
The use of suboptimal antiretroviral therapy when applying for migration to Australia: a case series
Tran D, Allan B, Stratigos A, ODonnell D, Heath-Paynter D, Cogle A, et al.
Sex Health
. 2024 Apr;
21.
PMID: 38683940
Background Australia imposes restrictions for people living with HIV (PLHIV) applying for permanent residency (PR), including spending less than AUD51,000 on medical costs over 10years. Some PLHIV opted for suboptimal...
2.
Pitman M, Meagher N, Price D, Rhodes A, Chang J, Scher B, et al.
J Virus Erad
. 2023 Sep;
9(3):100345.
PMID: 37753336
Introduction: Antiretroviral therapy for people living with HIV-1 must be taken lifelong due to the persistence of latent virus in long-lived and proliferating CD4 T cells. Vitamin D is a...
3.
Tai A, Landao-Bassonga E, Chen Z, Tran M, Allan B, Ruan R, et al.
Biomater Transl
. 2023 May;
4(1):41-50.
PMID: 37206304
Guided bone regeneration is one of the most common surgical treatment modalities performed when an additional alveolar bone is required to stabilize dental implants in partially and fully edentulous patients....
4.
Yu F, Hsiao Y, Park S, Kambara K, Allan B, Brough G, et al.
AIDS Behav
. 2022 Nov;
27(4):1287-1303.
PMID: 36348191
Long-acting injectable regimens for HIV treatment have been developed which are less frequent, more discreet, and more desirable for some people living with HIV (PLHIV) and may help reduce stigma-related...
5.
Brown G, Reeders D, Cogle A, Allan B, Howard C, Rule J, et al.
J Int AIDS Soc
. 2022 Jul;
25 Suppl 1:e25924.
PMID: 35818874
Introduction: Structural stigma in the global HIV response is a "moving target" that constantly evolves as the epidemic changes. Tackling structural stigma requires an understanding of the drivers and facilitators...
6.
Pederson S, Biondi D, Allan B, Cady R, Schaeffler B, Baker B, et al.
Front Immunol
. 2021 Nov;
12:765822.
PMID: 34759933
Background: Eptinezumab is a humanized monoclonal antibody that selectively binds calcitonin gene-related peptide and is indicated for the preventive treatment of migraine in adults. This analysis characterizes the immunogenic profile...
7.
Updated Australian guidance for health care providers about "undetectable = untransmittable" for HIV
McMahon J, Allan B, Grace D, Holas N
Med J Aust
. 2021 Aug;
215(5):201-202.e1.
PMID: 34341994
No abstract available.
8.
Crawford D, Allan B, Cogle A, Brown G
HIV Med
. 2021 Jul;
22 Suppl 1:3-14.
PMID: 34296511
Objectives: While current antiretroviral and care strategies can effectively suppress HIV, achieving optimal quality of life (QoL) requires a wider consideration of clients' well-being, the complexity of individuals' lives and...
9.
Smith T, Janelidze M, Chakhava G, Cady R, Hirman J, Allan B, et al.
Clin Ther
. 2021 Apr;
43(4):791.
PMID: 33814199
No abstract available.
10.
Kudrow D, Cady R, Allan B, Pederson S, Hirman J, Mehta L, et al.
BMC Neurol
. 2021 Mar;
21(1):126.
PMID: 33740902
Background: Eptinezumab, an anti-calcitonin gene-related peptide monoclonal antibody recently approved in the United States for preventive treatment of migraine in adults, was found to be well tolerated in double-blind, placebo-controlled...